Ipilimumab and Nivolumab as First-Line Treatment of Patients with Renal Cell Carcinoma: The Evidence to Date

by Sheng IY, Ornstein MC
Published 2020-06-01

Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook

by Gopalakrishnan D, Koshkin VS, Ornstein MC, Papatsoris A, Grivas P
Published 2018-06-01